Leap Therapeutics Inc
NASDAQ:LPTX
Income Statement
Earnings Waterfall
Leap Therapeutics Inc
Income Statement
Leap Therapeutics Inc
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||
| Interest Expense |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+100%
|
1
+50%
|
2
+33%
|
2
N/A
|
2
N/A
|
2
N/A
|
2
N/A
|
1
-25%
|
1
-33%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(28)
|
(25)
|
(32)
|
(34)
|
(32)
|
(28)
|
(28)
|
(28)
|
(31)
|
(33)
|
(35)
|
(34)
|
(33)
|
(31)
|
(31)
|
(31)
|
(30)
|
(33)
|
(35)
|
(40)
|
(43)
|
(44)
|
(51)
|
(54)
|
(57)
|
(59)
|
(87)
|
(86)
|
(57)
|
(59)
|
(66)
|
(69)
|
(70)
|
(71)
|
(62)
|
|
| Selling, General & Administrative |
(4)
|
(6)
|
(8)
|
(9)
|
(10)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(13)
|
(12)
|
(11)
|
|
| Research & Development |
(23)
|
(19)
|
(24)
|
(26)
|
(23)
|
(20)
|
(20)
|
(19)
|
(22)
|
(24)
|
(26)
|
(26)
|
(24)
|
(22)
|
(21)
|
(21)
|
(20)
|
(23)
|
(24)
|
(29)
|
(32)
|
(33)
|
(40)
|
(42)
|
(45)
|
(47)
|
(44)
|
(43)
|
(44)
|
(46)
|
(52)
|
(56)
|
(57)
|
(59)
|
(51)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
(30)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(28)
N/A
|
(25)
+8%
|
(32)
-28%
|
(34)
-5%
|
(32)
+5%
|
(28)
+12%
|
(28)
+1%
|
(28)
0%
|
(31)
-9%
|
(33)
-8%
|
(35)
-5%
|
(34)
+2%
|
(33)
+2%
|
(31)
+7%
|
(30)
+3%
|
(30)
+1%
|
(29)
+4%
|
(31)
-10%
|
(33)
-7%
|
(38)
-14%
|
(41)
-9%
|
(43)
-4%
|
(50)
-17%
|
(53)
-6%
|
(57)
-6%
|
(59)
-4%
|
(87)
-46%
|
(86)
+1%
|
(57)
+33%
|
(59)
-3%
|
(66)
-11%
|
(69)
-5%
|
(70)
-2%
|
(71)
-2%
|
(62)
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(0)
|
(1)
|
0
|
1
|
(5)
|
(5)
|
(4)
|
7
|
12
|
13
|
11
|
0
|
(1)
|
0
|
1
|
1
|
2
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
1
|
2
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
0
|
0
|
(30)
|
0
|
0
|
0
|
0
|
0
|
(5)
|
|
| Total Other Income |
3
|
4
|
4
|
5
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(26)
N/A
|
(22)
+13%
|
(29)
-31%
|
(29)
+2%
|
(30)
-4%
|
(31)
-4%
|
(32)
-1%
|
(31)
+1%
|
(23)
+26%
|
(21)
+9%
|
(22)
-5%
|
(23)
-6%
|
(33)
-41%
|
(32)
+4%
|
(30)
+6%
|
(29)
+3%
|
(28)
+4%
|
(29)
-7%
|
(32)
-10%
|
(37)
-13%
|
(41)
-11%
|
(42)
-3%
|
(49)
-18%
|
(53)
-8%
|
(54)
-2%
|
(86)
-58%
|
(82)
+4%
|
(81)
+2%
|
(81)
-1%
|
(53)
+34%
|
(60)
-13%
|
(64)
-6%
|
(67)
-5%
|
(69)
-2%
|
(65)
+5%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
|
| Income from Continuing Operations |
(26)
|
(22)
|
(29)
|
(29)
|
(41)
|
(42)
|
(43)
|
(43)
|
(23)
|
(21)
|
(22)
|
(23)
|
(33)
|
(32)
|
(30)
|
(29)
|
(28)
|
(29)
|
(32)
|
(37)
|
(41)
|
(42)
|
(49)
|
(53)
|
(55)
|
(86)
|
(82)
|
(81)
|
(81)
|
(53)
|
(60)
|
(65)
|
(68)
|
(69)
|
(66)
|
|
| Net Income (Common) |
(26)
N/A
|
(23)
+12%
|
(30)
-30%
|
(29)
+2%
|
(30)
-3%
|
(31)
-3%
|
(31)
-1%
|
(31)
+1%
|
(23)
+26%
|
(21)
+7%
|
(22)
-5%
|
(24)
-6%
|
(33)
-40%
|
(42)
-25%
|
(40)
+4%
|
(39)
+2%
|
(38)
+3%
|
(29)
+22%
|
(32)
-10%
|
(37)
-13%
|
(41)
-11%
|
(42)
-3%
|
(49)
-18%
|
(53)
-8%
|
(55)
-2%
|
(86)
-58%
|
(82)
+4%
|
(81)
+2%
|
(81)
0%
|
(53)
+34%
|
(60)
-13%
|
(65)
-7%
|
(68)
-5%
|
(69)
-2%
|
(66)
+5%
|
|
| EPS (Diluted) |
-27.27
N/A
|
-32.63
-20%
|
-31.48
+4%
|
-30.98
+2%
|
-32.71
-6%
|
-24.84
+24%
|
-21.36
+14%
|
-21.22
+1%
|
-16.36
+23%
|
-11.16
+32%
|
-9.81
+12%
|
-9.94
-1%
|
-14.73
-48%
|
-13.15
+11%
|
-7.58
+42%
|
-5.09
+33%
|
-6.34
-25%
|
-4.92
+22%
|
-5.43
-10%
|
-4.66
+14%
|
-4.73
-2%
|
-4.73
N/A
|
-5.58
-18%
|
-4.7
+16%
|
-4.82
-3%
|
-6.65
-38%
|
-5.6
+16%
|
-3
+46%
|
-3.98
-33%
|
-1.97
+51%
|
-1.54
+22%
|
-1.57
-2%
|
-1.81
-15%
|
-1.68
+7%
|
-1.59
+5%
|
|